rs4933977
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033100.4(CDHR1):c.863-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0499 in 1,609,556 control chromosomes in the GnomAD database, including 3,888 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.085 ( 907 hom., cov: 32)
Exomes 𝑓: 0.046 ( 2981 hom. )
Consequence
CDHR1
NM_033100.4 intron
NM_033100.4 intron
Scores
2
Splicing: ADA: 0.00002035
2
Clinical Significance
Conservation
PhyloP100: 1.27
Genes affected
CDHR1 (HGNC:14550): (cadherin related family member 1) This gene belongs to the cadherin superfamily of calcium-dependent cell adhesion molecules. The encoded protein is a photoreceptor-specific cadherin that plays a role in outer segment disc morphogenesis. Mutations in this gene are associated with inherited retinal dystrophies. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-84205818-C-T is Benign according to our data. Variant chr10-84205818-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 262219.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDHR1 | NM_033100.4 | c.863-9C>T | intron_variant | ENST00000623527.4 | NP_149091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDHR1 | ENST00000623527.4 | c.863-9C>T | intron_variant | 1 | NM_033100.4 | ENSP00000485478.1 | ||||
CDHR1 | ENST00000332904.7 | c.863-9C>T | intron_variant | 1 | ENSP00000331063.3 | |||||
CDHR1 | ENST00000372117.6 | c.242-9C>T | intron_variant | 2 | ENSP00000361189.4 | |||||
CDHR1 | ENST00000624091.1 | n.139C>T | non_coding_transcript_exon_variant | 2/4 | 5 | ENSP00000485460.1 |
Frequencies
GnomAD3 genomes AF: 0.0853 AC: 12972AN: 152096Hom.: 907 Cov.: 32
GnomAD3 genomes
AF:
AC:
12972
AN:
152096
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0758 AC: 18935AN: 249874Hom.: 1244 AF XY: 0.0703 AC XY: 9503AN XY: 135132
GnomAD3 exomes
AF:
AC:
18935
AN:
249874
Hom.:
AF XY:
AC XY:
9503
AN XY:
135132
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0462 AC: 67324AN: 1457342Hom.: 2981 Cov.: 30 AF XY: 0.0468 AC XY: 33967AN XY: 725182
GnomAD4 exome
AF:
AC:
67324
AN:
1457342
Hom.:
Cov.:
30
AF XY:
AC XY:
33967
AN XY:
725182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0853 AC: 12991AN: 152214Hom.: 907 Cov.: 32 AF XY: 0.0860 AC XY: 6399AN XY: 74418
GnomAD4 genome
AF:
AC:
12991
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
6399
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
477
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Cone-Rod Dystrophy, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at